Welcome to LookChem.com Sign In|Join Free
  • or
ethyl (2R)-2-benzyl-3-[(3,5-dimethoxybenzyl)amino]-2-hydroxy-3-oxopropanoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1430104-92-9

Post Buying Request

1430104-92-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1430104-92-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1430104-92-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,3,0,1,0 and 4 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1430104-92:
(9*1)+(8*4)+(7*3)+(6*0)+(5*1)+(4*0)+(3*4)+(2*9)+(1*2)=99
99 % 10 = 9
So 1430104-92-9 is a valid CAS Registry Number.

1430104-92-9Relevant academic research and scientific papers

Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonists

Yang, Christine,Shen, Hong C.,Wu, Zhicai,Chu, Hong D.,Cox, Jason M.,Balsells, Jaume,Crespo, Alejandro,Brown, Patricia,Zamlynny, Beata,Wiltsie, Judyann,Clemas, Joseph,Gibson, Jack,Contino, Lisa,Lisnock, Jeanmarie,Zhou, Gaochao,Garcia-Calvo, Margarita,Bateman, Tom,Xu, Ling,Tong, Xinchun,Crook, Martin,Sinclair, Peter

, p. 4388 - 4392 (2013)

Novel oxazolidinedione analogs were discovered as potent and selective mineralocorticoid receptor (MR) antagonists. Structure-activity relationship (SAR) studies were focused on improving the potency and microsomal stability. Selected compounds demonstrat

MINERALOCORTICOID RECEPTOR ANTAGONISTS

-

, (2013/04/25)

The present invention is directed to compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, that are potentially useful for treating aldosterone-mediated diseases. The invention furthermore relates to processes for preparing compounds of the Formula (I), to their possible use in the treatment of the above mentioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical compositions which comprise compounds of the Formula (I).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1430104-92-9